Novartis Q3 Results and Pipeline Progress
Novartis, an innovative medicines company, delivers solid sales and core operating income growth with strong pipeline progress in Q3 and reaffirms FY 2025 guidance.
Company Overview
Novartis works to reimagine medicine, improving and extending people's lives, empowering patients, healthcare professionals, and societies in the face of serious disease, with medicines reaching 296 million people worldwide.
Resources and Commitments
- Information for patients and caregivers: clinical trial recruiting, managed access programs, funding opportunities, and side effects reporting.
- Resources for physicians and healthcare professionals: clinical trial recruiting, grant funding, congresses, and country-level information.
- Commitments to environmental, social, and governance: providing access to innovative medicines, protecting the environment, and upholding high ethical standards.
Discover how Novartis turns breakthrough science into transformative, high-value treatments.
Learn about Novartis' positive impact on the world through the Novartis in Society Integrated Report.
Author's summary: Novartis reports solid Q3 growth.
More News
- Study Finds Around a Quarter of Polymarket Trades Are Fake
- Military veterans answer new call to service in Arizona's booming trades industry
- NTSB Briefing Reveals CVR Data in UPS Jet Crash
- 4-alarm fire in North Baltimore has been contained, SKY 11 reports
- New WWE ID Signing Announced - WrestleTalk
- Velvet-Wood uranium mine construction begins
- Stranger Things stars hit red carpet for Netflix hit's final season premiere
- Natalia Dyer Stuns in Red Hot Dress at Premiere of ‘Stranger Things’ Season 5
- Chelsea eyeing free agent deal for Real Madrid star - Get Spanish Football News
- Netflix surprise releases first five minutes of ‘Stranger Things’ season 5